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Electrochemotherapy (ECT) is a promising new approach to
fighting cancer and has successfully been applied to regressing
tumours in several animal models and clinical trials with
squamous cell carcinomas, basal cell carcinomas, metastatic
melanomas and liver tumours (Sersa et al, 1995; Glass et al, 1996;
Heller et al, 1996; Mir et al, 1997; Ramirez et al, 1998, Belehradek
et al, 1993). During ECT treatment, antineoplastic drugs with low
cell membrane permeability, e.g. bleomycin (Poddevin et al,
1991), are delivered into cells by short and intense electric field
pulses. These field pulses with a field strength of approximately
130 000 Vm–1 are applied for microseconds and have been
discussed to transiently increase the permeability of cell
membranes by electroporation (Glass et al, 1996; Nishi et al,
1997). Owing to the high field strength of the applied electrical
fields, pulses have to be administered locally at the solid tumour
site of avoid serious side-effects of the electrical field on the
patient. This implicates that the enhanced delivery of the anti-
cancer agent is restricted to the area that has been electrically
treated. Unlocalized tumours, however, remain untreated, making
desirable an ECT approach that uses fairly lower field strengths
which can be more generally applied to tissues or whole organs.
In the present study, we used multicellular prostate tumour
spheroids of the DU-145 cell line to investigate whether treatment
with low electrical field strengths increases the uptake and toxicity
of the cell membrane-permeant anthracycline doxorubicin.
Tumour spheroids were treated for 90 s with a single electrical
field pulse of a field strength that has previously been shown to
stimulate tumour cell proliferation (Sauer et al, 1997; Wartenberg
et al, 1997). An experimental approach for ECT based on stimula-
tion of cell proliferation should be promising since chemothera-
peutics are known to be far more effective in rapid cycling as
compared to slow-cycling tumour cells.
MATERIALS AND METHODS
Culture technique of multicellular tumour spheroids
The human prostate cancer cell line DU-145 was kindly provided
by Dr J Carlsson, Uppsala, Sweden. Cells were cultured in Ham’s
F10 medium (Gibco, Live Technologies, Helgerman Court, MD,
USA) as described previously (Sauer et al, 1997) Spheroids were
grown from single cells (passages 2–15) seeded in 250 ml
siliconated spinner flasks (Tecnomara, Fernwald, Germany) at
1  ´ 105 cells ml–1. The spinner flask medium (175 ml) was stirred
(20 rpm) using a stirrer system (Tecnomara) and partly changed
every day. For the experiments, tumour spheroids of a size class of
150 ± 30 mm were used.
Enzymatic dissociation of multicellular tumour
spheroids
Dissociation of multicellular spheroids was performed as
described previously (Wartenberg et al, 1998). In brief, spheroids
were washed in phosphate-buffered saline (PBS) and placed in a
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Petri dish containing 1 ml 0.2% Trypsin and 0.05% ethylene-
diaminetetraacetic acid (EDTA) in PBS. The spheroids were incu-
bated for 5 min at 37°C and agitated every 30 s. Thereafter they
were triturated and the enzymatic reaction was stopped by addition
of 4 ml cell culture medium. After centrifugation at 80 g for 5 min
the cells were resuspended in cell culture medium.
Electrical field treatment
A schematic scheme of the experimental setup is depicted in Figure
1. For electropulse experiments, multicellular tumour spheroids
were suspended in low ionic content, N-2-hydroxyethylpiperazine-
N¢-2-ethane-sulphonic acid (HEPES) (5 mM, pH 7.2) buffered
‘pulsing medium’ (Rols and Teissié, 1990) containing 255 mM
sucrose, 1 mM calcium chloride and 1 mM magnesium chloride.
The pulsing buffer had a conductivity of 500 mS cm–1. Spheroids
were placed into an incubation chamber between stainless (V4A)
steel electrodes, with an electrode distance of 2 mm and an elec-
trode area of 0.4 cm2. The electrodes were connected to a custom-
made voltage generator that generated square-wave voltage pulses.
One single electric field pulse with a field strength of 500 Vm–1 and
a duration of 90 s was applied to the spheroids. The total current in
the chamber amounted to 1 mA. The magnetic flux density in the
proximity of the multicellular tumour spheroids was calculated to
0.079 mT, which is below the average laboratory noise level for low
frequency electromagnetic fields (Cameron et al, 1993). After
electric field treatment tumour spheroids were resuspended in F10
medium and incubated at 37°C for 90 min. In control experiments,
we ensured that no water electrolysis, pH or temperature shifts
occurred during the electropulse experiments.
Doxorubicin uptake experiments and confocal laser
scanning microscopy
For doxorubicin uptake experiments multicellular tumour spher-
oids were suspended in pulsing buffer supplemented with 4 mM
doxorubicin (Sigma, Deisenhofen, Germany). Electropulsing in
the presence of doxorubicin was performed under the optical
control of an inverted confocal laser scanning microscope (CLSM
410, Carl Zeiss, Jena, Germany) equipped with an immersion
corrected, 25 ´, numerical aperture 0.83, objective (Plan Neofluar,
Carl Zeiss). Images of 512 ´ 512 pixels, 8 bits, were recorded
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Figure 1 Setup for electrical field treatment of multicellular tumour spheroids. Spheroids were placed into an incubation chamber filled with ‘pulsing buffer’.
The lateral walls of the chamber were formed by stainless (V4A) steel electrodes with an electrode distance of 2 mm and an electrode area of 0.4 cm2. A
computer-controlled pulse generator generated square wave pulses. During electrical field treatment the spheroids were examined by confocal laser scanning
microscopy (CLSM). Fluorescence was recorded by photomultiplier tubes (PMT) and digital images were reconstructed by the CLSM image analysis software.
By means of a filter changer (ND filter wheel) the laser beam scanning the tumour spheroids could be attenuated by a factor of approximately 1000. Flashes for
photobleaching experiments could be applied within milliseconds1206 H Sauer et al
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every 60 s and were stored automatically to the host memory of
the computer unit of the confocal setup. Image analysis was
performed as described previously (Wartenberg et al, 1997). For
the determination of doxorubicin retention, spheroids treated with
electrical fields in the presence of 4 mM doxorubicin were trans-
ferred to F10 medium supplemented with 4 mM doxorubicin.
Doxorubicin fluorescence was evaluated 90 min after addition of
doxorubicin. Excitation of doxorubicin was performed using the
543-nm line of a helium-neon laser of the confocal setup. Emission
was recorded using a longpass LP 570-nm filter set. In the experi-
ments with free radical scavengers, tumour spheroids were pre-
incubated for 2 h with either 2.5 mM dehydroascorbate (DHA),
dissolved in pulsing buffer or for 24 h with 30 mM a-tocopherol
(vitamin E), dissolved in dimethyl sulphoxide (DMSO). Final
DMSO concentrations were < 0.1%.
Determination of spheroid growth
Multicellular tumour spheroids were treated with a single elec-
trical field pulse (500 Vm–1, 90 s) either in the presence or absence
of 4 mM doxorubicin; a third sample was treated with doxorubicin
alone; and a negative control remained untreated. After 3 h, the
spheroids were washed three times in F10 medium and further
incubated for 3 days. Spheroid sizes were determined after
washout of doxorubicin prior to the post-incubation period and
subsequently after 24 and 72 h. Spheroid volumes were calculated
according to 4/3 ´p´rs
2 ´ rl, where rs represents the small radius
of the respective spheroids and rl and large radius.
Determination of fluid phase uptake and lethal staining
of cells
For fluid phase uptake studies the hydrophilic, membrane-imper-
meant tracer Lucifer yellow CH (Sigma, Deisenhofen, Germany)
was used. Either multicellular spheroids or single cells enzymati-
cally dissociated from spheroids were suspended in pulsing buffer
containing Lucifer yellow in a final concentration of 20 mM, and
transferred to the pulsing chamber mounted to the stage of the
confocal setup. Fluid uptake was continuously monitored before,
during and after electrical field treatment with field strengths
ranging from 500 Vm–1 to 3000 Vm–1, applied for 90 s. Reversible
and irreversible membrane breakdown was evaluated as intra-
cellular increase of Lucifer yellow fluorescence. Excitation was
performed using the 488-nm line of the argon-ion laser of the
confocal setup. Emission was recorded using a longpass LP515-
nm filter set.
Lethal staining was performed using the lethal cell marker
Ethidium homodimer-1 (Ethd-1) (Molecular Probes, Eugene, OR,
USA). Spheroids were treated with a field strength of 3000 Vm–1
for 90 s and were incubated 15 min subsequent to electrical field
treatment for 30 min at room temperature with Ethd-1 (final
concentration 12 mM). Excitation of Ethd-1 was performed using
the 488-nm line of the argon-ion laser. Emission was recorded
using a longpass LP590-nm filter set.
Determination of intracellular redox state
Intracellular redox state levels were measured using the
fluorescent dye 2¢,7¢-dichlorofluorescein diacetate (H2DCFDA)
(Molecular Probes), which is a non-polar compound that is
converted into a non-fluorescent polar derivative by cellular
esterases after incorporation into cells. H2DCF is membrane
impermeable and is rapidly oxidized to the highly fluorescent
2¢,7¢-dichlorofluorescein (DCF) in the presence of intracellular
ROS (Frenkel and Gleichauf, 1991). For the experiments,
multicellular tumour spheroids were incubated in F10 medium
containing 20 mM H2DCFDA for 30 min at room temperature.
Spheroids were then washed twice in F10 medium, once in pulsing
buffer and transferred to the experimental chamber. For fluores-
cence excitation, the 488-nm band of the argon ion laser of the
confocal setup was used. Emission was recorded using a longpass
LP515-nm filter set.
Determination of lipid peroxidation
Lipid peroxidation of membrane preparations was measured by
use of a colorimetrically based kit (Calbiochem-Novabiochem
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Figure 2 Increased doxorubicin uptake in multicellular tumour spheroids
treated with a single electrical field pulse (500 Vm–1, 90 s) in the presence of
4 mM doxorubicin. (A) Doxorubicin distribution in representative spheroids;
left side: untreated control spheroid; right side: electrical field treated
spheroid. The images were recorded 90 min after electrical field application.
The bar represents 100 mm. (B) Relative doxorubicin fluorescence in control
and electrical field treated whole-mount multicellular spheroids 90 min after
field application. The doxorubicin fluorescence in the control sample was set
to 100%. About 30 spheroids in four independent experiments were used for
the determination of each data point. *P < 0.05, significantly different from
controlElectric field-mediated doxorubicin uptake 1207
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International, Inc. San Diego, CA, USA). In brief, membrane
preparations of 105 cells containing end products of lipid per-
oxidation, e.g. malonaldehyde and 4-hydroxy-2(E)-nonenal, were
reacted with the chromophore N-methyl-2-phenylindole and with
methanesulphonic acid (40 min at 45°C). The samples were
cooled on ice and centrifuged at 10 000 g for 5 min at room
temperature. The absorbance of the supernatant at 590-nm and
25°C was read on a spectrofluorometer. The combined concentra-
tion of malondialdehyde and 4-hydroxy-2(E)-nonenal was deter-
mined from a standard curve.
Fluorescence after photobleaching (FRAP) experiments
FRAP experiments were performed using the line-scanning
microphotolysis technique recently developed by Wedekind et al
(1996). In brief, electrical field (500 Vm–1, 90 s)-treated and
untreated control multicellular tumour spheroids were labelled 2 h
after field exposure for 15 min with the fluorescent lipid analogue
2-(6-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)hexanoyl-1-hexade-
canoyl-sn-glycero-3-phosphocholine (NBD-C6-HPC) (Molecular
Probes) dissolved in a final concentration of 10 mg ml–1 in E1 buffer
containing 135 mM sodium chloride, 5.4 mM potassium chloride,
1.8 mM calcium chloride, 1 mM magnesium chloride, 10 mM
glucose, 10 mM HEPES (pH 7.4 at 23°C). They were subsequently
washed three times in E1 buffer and transferred to an incubation
chamber mounted on the stage of the confocal setup. The initial
fluorescence before photobleaching was evaluated by recording a
512 ´ 512 pixel x,y scan image. From this prebleach image the mean
fluorescence was determined in the region of interest predisposed
for photobleaching. The confocal microscope was subsequently
switched to the line scan mode and the laser power was increased
from 2.5 mW to 25 mW. During line scanning, which was
performed for 3 s, the laser beam was repetitively scanned at high
speed (3 ms per line scan) along a selected line. After photolysis
along the selected line, full frame images (512 ´ 512 pixel) were
recorded in intervals of 15 s, and the fluorescence recovery in the
centre of the line was determined using an overlay mask. The data
were plotted for display by non-linear least-squares fit of the data
and the lipid lateral diffusion coefficient was calculated from the
recovery curves according to Koppel et al (1979) who described the
relationship between fluorescence F at the scanning point Dx from
the centre of the bleached area at time t by the following equations
F(Dx,t) = F0{[1-ba2(t)]exp[–(Dx)2/w2 (t)]} – {(1–b)a0exp[–(Dx)2/w0
2]}(1)
a2 = a0/(1 + t/tD) (2)
tD = w0
2/4D (3)
where b represents the size of the mobile fraction, a0 is a constant
that characterizes the extent of bleaching, w0 is the 1/e radius of
the laser beam size, tD is the diffusion time, and D is the diffusion
coefficient.
Statistical analysis
Data are given as mean values ± s.e.m. with n denoting the number
of experiments. Student’s t-test for unpaired data was applied as
appropriate. A value of P < 0.05 was considered significant.
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Figure 3 Time course of doxorubicin uptake in multicellular spheroids.
(A) Doxorubicin fluorescence increase prior, during and following electrical
field (500 Vm–1, 90 s) treatment. (B) Presentation of doxorubicin fluorescence
increase during electrical field treatment. The electrical field was applied
during the time indicated by the vertical dashed lines. Note that doxorubicin
uptake is not enhanced during electrical field application, indicating that the
used field strength did not induce membrane breakdown processes.
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Figure 4 Doxorubicin retention in electrical field treated (500 Vm–1, 90 s)
multicellular spheroids. Electrical field treated spheroids (hatched bars) and
an untreated control (open bars) were incubated with 4 mM doxorubicin during
electrical field application and post-incubated in the presence of doxorubicin
for 90 min. Thereafter, external doxorubicin was washed out and doxorubicin
fluorescence was evaluated following an incubation period of 90 min in
doxorubicin-free F10 medium. About 30 spheroids in three independent
experiments were used for the determination of each data point. *P < 0.05,
significantly different from control1208 H Sauer et al
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RESULTS
Enhanced doxorubicin uptake and retention in
multicellular tumour spheroids treated with electrical
fields
When multicellular tumour spheroids were treated with a single elec-
trical field pulse with a field strength of 500Vm–1 and a duration of
90s, which has previously been shown to stimulate tumour growth
(Sauer et al, 1997; Wartenberg et al, 1997), a significant increase
by 67 ±3% of doxorubicin uptake (Figure 2 A,B) was observed after
90min (n= 4). Doxorubicin fluorescence was homogenously
distributed within the tissue, i.e. no preferential accumulation at the
cathode- or anode-facing was observed. The time course of doxo-
rubicin uptake was monitored by CLSM during electrical field treat-
ment. Figure 3 A,B shows that doxorubicin uptake is not enhanced
during, but following, the electrical field pulse, indicating that the
observed effect is not owing to either reversible or irreversible
membrane breakdown (n= 3). The observed increase in doxorubicin
uptake after electrical field treatment may be at least partially owing
to reduced doxorubicin efflux. Therefore, doxorubicin retention was
assessed in electrical field-treated tumour spheroids 90min after
doxorubicin removal from the external medium. Figure 4 shows that
in the electrical field-treated sample a significant efflux of doxo-
rubicin after washout of external doxorubicin occurred. This
indicates that the observed enhancement of doxorubicin retention
following electrical field treatment may be owing to physical
changes in membrane permeability which affect both efflux and
influx kinetics of doxorubicin. However, doxorubicin retention after
washout of external doxorubicin was still about 20% enlarged in the
electrical field treated sample as compared to control (n= 3) which
presumably results from intracellular binding of the compound.
To exclude that either reversible or irreversible membrane break-
down occurred during and after electrical field treatment, spheroids
and single cells enzymatically dissociated from spheroids were
treated with different field strengths in the presence of the polar
fluorescence dye Lucifer yellow CH. Membrane breakdown
processes should result in an increased uptake of this fluid phase
marker. Figure 5 demonstrates that no fluid phase uptake of Lucifer
yellow CH occurred when field strengths of 500Vm–1 and
1000Vm–1 (not shown) were applied for 90s. A marked fluid phase
uptake owing to electrical field treatment was observed with a field
strength of 1500Vm–1. The Lucifer yellow uptake occurred during
electrical field application and remained on a sustained plateau, indi-
cating reversible membrane breakdown (n= 3). Treatment with a
field pulse of 2000Vm–1 resulted in fluid phase uptake during field
application, followed by a further rise of Lucifer yellow fluorescence
shortly after treatment, which is indicative for irreversible membrane
breakdown (n= 3). When multicellular tumour spheroids were
treated with an electrical field pulse of 3000Vm–1 and Lucifer yellow
staining was co-localized with Ethd-1 staining of lethal cells, an
increased cell lethality was observed at the anode-facing pole of the
spheroid, indicating more pronounced cell membrane potential
changes resulting in irreversible membrane breakdown processes
(Figure 6) (n= 3).
Doxorubicin toxicity is increased after DC electrical
field treatment of multicellular tumour spheroids
To test whether adjuvant DC electrical field treatment (500Vm–1,
90s) augmented doxorubicin toxicity, multicellular tumour spheroids
were electrical field-treated in the presence of doxorubicin, and
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Figure 5Time course of fluid phase uptake of Lucifer yellow CH in single
cells treated with different field strengths. Single cells were enzymatically
dissociated from multicellular tumour spheroids. (A) Control; (B) 500Vm–1,
90s; (C) 1500Vm–1, 90s; (D) 2000Vm–1, 90s. The electrical field was
applied during the time indicated by the vertical dashed lines
100 mm
+–
Figure 6Lucifer yellow CH fluid phase uptake and Ethd-1 lethal staining in
a representative multicellular tumour spheroid treated with a 3000Vm–1, 90s
electrical field. Shown is a false colour overlay of a transmission image
(blue), a Lucifer yellow fluorescence image (green), and a Ethd-1
fluorescence image (red). Note that cell lethality is increased at the anode-
facing side of the spheroid. The bar represents 100mmElectric field-mediated doxorubicin uptake 1209
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spheroid growth was monitored. Figure 7 shows the growth kinetics
of control spheroids, spheroids treated with doxorubicin alone and
spheroids treated with a single electrical field pulse (500 Vm–1, 90 s)
in the presence or absence of doxorubicin. As reported previously
(Sauer et al, 1997; Wartenberg et al, 1997), the electrical field pulse
led to an enhancement of tumour growth. However, electrical field
treatment in the presence of doxorubicin resulted in a significantly
decreased growth kinetics as compared to spheroids treated with
doxorubicin alone (n = 3).
The increased doxorubicin uptake is owing to the
generation of intracellular reactive oxygen species by
electrical field treatment
To investigate underlying mechanisms for the observed increase of
doxorubicin uptake following electrical field treatment, intracellular
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Figure 7 Growth kinetics of multicellular tumour spheroids after electrical
field (500 Vm–1, 90 s) treatment. One sample of spheroids was treated with a
single electrical field pulse (500 Vm–1, 90 s) in the presence of doxorubicin
(4 mM) (t t). A second sample was electrical field treated in the absence of
doxorubicin (n n). A third sample was treated with doxorubicin (4 mM) alone
(s s). A control sample remained untreated (l l). Note that electrical field
treatment in the absence of doxorubicin enhanced the growth kinetics of
tumour spheroids as previously reported (Sauer et al, 1997)
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Figure 8 ROS generation during and following treatment of multicellular
tumour spheroids with a single electrical field pulse (500 Vm–1, 90 s).
Representative trace of normalized dichlorofluorescein (DCF) fluorescence.
The electrical field was applied during the time indicated by the dashed lines
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Figure 9 Effect of 100 nM hydrogen peroxide on the doxorubicin uptake in
multicellular spheroids. Spheroids were treated for 90 min with H2O2 in the
presence of doxorubicin and doxorubicin fluorescence was evaluated in
whole-mount spheroids. About 30 spheroids in four independent experiments
were used for the determination of each data point. *P < 0.05, significantly
different from control
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Figure 10 Effects of the radical scavengers DHA (2.5 mM) (A) and a-
tocopherol (vitamin E) (30 mM) (B) on doxorubicin uptake following electrical
field (500 Vm–1, 90 s) treatment. Doxorubicin fluorescence was determined
after an incubation period of 90 min in: (1) an untreated control; (2) an
untreated control preincubated for 2 h and 24 h with DHA and a-tocopherol
respectively; (3) an electrical field treated sample; (4) in an electrical field
treated sample after preincubation with radical scavengers. About 30
spheroids in three independent experiments were used for the determination
of each data point. *P < 0.05, significantly different from control1210 H Sauer et al
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reactive oxygen species (ROS) were determined using DCF as an
indicator. Figure 8 shows that during electrical field treatment
ROS were generated (n = 5). The amount of ROS generated was
equivalent to the DCF signal elicited with 50–100 nM hydrogen
peroxide (Wartenberg et al, 1997). Consequently, nanomolar
concentrations (100 nM) of externally added hydrogen peroxide
mimicked the effect of the electrical field on doxorubicin uptake
(see Figure 9), indicating that ROS generation subsequent to elec-
trical field treatment is sufficient to enhance doxorubicin uptake
(n = 4). This was further corroborated by experiments where
multicellular tumour spheroids were preincubated with the radical
scavengers dehydroascorbate (DHA) (2.5 mM) and a-tocopherol
(vitamin E) (30 mM). Figure 10 A,B clearly demonstrates that both
DHA and vitamin E (dissolved in DMSO) present during electrical
field treatment reduced doxorubicin uptake to the control level
of the untreated sample (n = 5), indicating that ROS generation
following electrical field treatment of multicellular tumour
spheroids is mediating the enhancement of doxorubicin uptake.
DMSO in the absence of a-tocopherol did not exert any effect on
the electrical field-induced doxorubicin accumulation (data not
shown).
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Figure 11 Determination of the lipid peroxidation end-products 4-HNE and
MDA in cell extracts from multicellular tumour spheroids treated with a single
electrical field pulse (500 Vm–1, 90 s). Evaluation of lipid peroxidation was
performed 2 h after electrical field treatment. *P < 0.05, significantly different
from control
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Figure 12 Lipid lateral diffusion is decreased in multicellular tumour spheroids treated with a single electrical field pulse (500 Vm–1, 90 s). FRAP experiments
were performed with spheroids stained with the fluorescent lipid analogue NBD-C6-HPC. Photobleaching along a preselected line was achieved by using the
line-scanning mode of the confocal microscope. The fluorescence images show (from the left to the right) the fluorescence recovery along the photobleached
line in a representative tumour spheroid 0 s, 150 s and 300 s after photobleaching. The traces show one of four experiments with comparable results. The
fluorescence recovery of at least three spheroids was determined to give one data pointElectric field-mediated doxorubicin uptake 1211
British Journal of Cancer (1999) 80(8), 1204–1213 © 1999 Cancer Research Campaign 
ROS generated during electrical field treatment of
multicellular tumour spheroids induce membrane lipid
peroxidation
ROS generated during electrical field treatment of multicellular
tumour spheroids may induce membrane lipid peroxidation,
resulting in an alteration of the permeability properties of the cell
membrane for doxorubicin. To assess lipid peroxidation malondi-
aldehyde (MDA) and 4-hydroxy-2(E)-nonenal (4-HNE), which
are end products of lipid peroxidation, were evaluated in cell
extracts of electrical field treated multicellular spheroids 2 h after
electrical field treatment (n = 3). Figure 11 shows that MDA and 4-
HNE in a concentration of 1.78 ± 0.26 nmol 10–6 cells were gener-
ated following electrical field treatment, indicating membrane
lipid peroxidation, which presumably resulted in changes of lipid
bilayer structure mediating increased doxorubicin uptake.
Electrical field-induced membrane rigidization
Lipid peroxidation following electrical field treatment of multicel-
lular tumour spheroids may alter the fluidity of cell membranes,
which may have effects on doxorubicin uptake and efflux kinetics.
To evaluate electrical field-induced changes in lipid mobility
FRAP experiments were performed using the fluorescent lipid
analogue NBD-C6-HPC and the line-scanning mode of the CLSM.
Our data show that fluorescence recovery after photobleaching
was reduced (Figure 12) when multicellular tumour spheroids had
been treated with an electrical field pulse 2 h prior to the FRAP
experiments, which resulted in a significantly decreased diffusion
coefficient D with 4.2 ´ 10–10 ± 1 ´ 10–10 cm2 s–1 as compared
to 2.7 ´ 10–10 ± 0.6 ´ 10–10 cm2 s–1 in the untreated control group
(n = 13 spheroids from four different spheroid cultures).
DISCUSSION
The electrical field strengths used in current approaches of ECT
are markedly above the critical field strengths for reversible or
irreversible membrane breakdown (Domenge et al, 1996; Heller et
al, 1997). Therefore, the enhancement of drug delivery following
electrical field treatment is thought to be mediated by electropora-
tion processes (Belehradek et al, 1994). Owing to severe side-
effects of the electrical fields on non-cancerous cells, the
applicability of ECT is reduced to the close vicinity of tumours.
The non-lethal low field strength (500 Vm–1, 90 s) applied in the
present study has previously been used by us to enhance the
growth kinetics of multicellular tumour spheroids and to recruit
quiescent cells in the depth of the tumour tissue for the cell cycle
(Sauer et al, 1997; Wartenberg et al, 1997). We have chosen this
proliferation-inducing electrical field strength since proliferation-
active cells have been demonstrated to be more susceptible
towards treatment with anticancer agents than dormant cells,
which have been reported to display features of resistance both
towards radiation and chemotherapy (Remvikos et al, 1993; Olive
and Durand, 1994; Hietanen et al, 1995; Wartenberg et al, 1998).
An approach using low field-strength non-toxic electrical fields
for ECT should be promising and may result in an increased effi-
cacy of chemotherapy. However, chemosensitization by stimula-
tion of tumour cell proliferation should assure the best possible
access of administered cytostatics to the tumours in order to avoid
a fatal ECT-induced enhancement in tumour growth.
The data of the present study demonstrate that treatment of multi-
cellular tumour spheroids with a single electrical field pulse of low
field-strength (500 Vm–1, 90 s) significantly increased doxorubicin
uptake and, consequently, doxorubicin toxicity. We could show that
the applied electrical field strength did not lead to either reversible
or irreversible membrane breakdown processes since – as described
previously (Sauer et al, 1997) – a field strength of 500 Vm–1 applied
to a spherical object of approximately 150 mm in diameter resulted
in a membrane potential change of 75 mV, which is far below the
critical membrane potential change of 0.5–1.5 V that has been
reported to be essential to induce membrane breakdown processes
(Weaver, 1993). Moreover, fluid phase uptake studies with the
hydrophilic fluorescence probe Lucifer yellow CH showed that fluid
phase uptake was not observed in single cells when field strengths of
500 Vm–1 (90 s) were applied. Experiments with different field
strengths revealed that reversible membrane breakdown occurred
with a critical electrical field strength of 1500 Vm–1 (90 s), which
resulted in a sustained rise in Lucifer yellow uptake during and
shortly following electrical field. Irreversible membrane breakdown
was observed at a field strength of 2000 Vm–1 (90 s) and was char-
acterized by an initial rise of Lucifer yellow fluorescence during
electrical field treatment, which was followed by a longlasting fluid
phase uptake. As previously described (Sauer et al, 1997), lethal
effects of the electrical field were found with a critical field strength
of 3000 Vm–1. Interestingly, cell lethality as indicated by Ethd-1
lethal cell staining was mainly observed at the anode-facing pole of
the spheroid. This effect can be explained by a superimposition of
the electrical field vector of the cell membrane potential and the
electrical field vector of the external electrical field, which are
acting in the same direction and lead to enlarged membrane poten-
tial changes at the anode-facing as compared to the cathode-facing
side of the spheroid (Sauer et al, 1997).
Electrical fields have been shown to change the intracellular
redox state (Wartenberg et al, 1997). An increase in intracellular
ROS may lead to lipid peroxidation and to altered permeability
properties of the cell membrane (Stanimirovic et al, 1995).
Changes in the intracellular redox state occurred during electrical
field treatment with a 500 Vm–1 (90 s) electrical field using the
fluorescence indicator DCF. Furthermore, the lipid peroxidation
products MDA and 4-HNE were detected in the cell homogenates
of tumour spheroids that had been treated with 500 Vm–1 (90 s)
electrical fields. To investigate whether electrical field generated
ROS were a prerequisite for the enhancement of doxorubicin
uptake, spheroids were incubated in the absence of an external elec-
trical field with 100 nM hydrogen peroxide, which resulted in a
doxorubicin uptake not significantly different from the uptake
observed after electrical field treatment, indicating that the elec-
trical field-generated ROS were equivalent to 100 nM externally
added hydrogen peroxide, as previously reported (Wartenberg et al,
1997). Moreover, incubation of multicellular tumour spheroids
with DHA, a radical scavenger of cytoplasmic ROS, and a-toco-
pherol, which inhibits lipid peroxidation by integration into the
plasma membrane (Susa et al, 1996), abolished the electrical field-
induced enhancement of doxorubicin uptake, indicating that the
observed effect was owing to changes in the cellular oxidized state.
The data of the present study suggest that lipid peroxidation
following electrical field treatment results in an increased
membrane permeability for doxorubicin, which affects both the
uptake and the efflux of the drug, but as a net effect results in
increased doxorubicin retention, presumably owing to intracellular
binding. It has been previously shown that lipid peroxidation
results in membrane rigidization with the consequence of altered
permeation properties of the cell membrane (Deliconstantinos etal, 1996; Garcia et al, 1997; Verstraeten et al, 1997). These data
were corroborated by the FRAP experiments of the present study,
which show that electrical field treatment of tumour spheroids
significantly decreased membrane fluidity, presumably owing to
the ROS generated by electrical field treatment.
The parameters that govern doxorubicin uptake in cells are still
a matter of debate. It has been shown that doxorubicin binds to
anionic phospholipids in the membrane which involves electro-
static interaction as well as penetration of the electrostatically
bound drug between the acyl chains (de Wolf et al, 1993;
Speelmans et al, 1994). The uncharged form of the drug is trans-
ported via passive diffusion, of which the driving force is the intra-
cellular acid pH and drug binding to intracellular targets (Harrigan
et al, 1993). In the cytoplasmic compartment, doxorubicin has
been demonstrated to generate ROS by doxorubicin quinone
reduction and redox-cycling (Keizer et al, 1990).
Significant scientific efforts have been undertaken to investigate
the cytotoxic effects of ROS generated by doxorubicin redox-
cycling, which have been related to ROS-dependent DNA damage
and lipid peroxidation with the consequence of impaired signal trans-
duction pathways (Keizer et al, 1990; Cummings et al, 1992).
However, the influence of the intracellular oxidized state and lipid
peroxidation on doxorubicin uptake is not well-documented. In a
recent study, doxorubicin toxicity was found to be enhanced after
incubation of breast cancer cells with polyunsaturated fatty acids,
which are known to induce lipid peroxidation. Incubation with
radical scavengers caused cell viability to return to the baseline level
of doxorubicin in the absence of polyunsaturated fatty acids
(Germain et al, 1998). Moreover, in a doxorubicin-resistant
mammary tumour cell line, lipid peroxidation levels were found to be
lower than in the wild-type cell line (Benchekroun et al, 1993). These
data point towards the notion that lipid peroxidation may be a general
mechanism by which the permeability of tumour cell membranes
may be increased for doxorubicin and its anthracycline derivatives.
The ECT approach elaborated in the present study for the in
vitro model of multicellular tumour spheroids demonstrates that
electrical field strengths far below the threshold of membrane
breakdown processes effectively increase doxorubicin uptake in
the tumour tissue. Changing the intracellular oxidized state of
tumours, or tumour-bearing organs, by low field-strength elec-
trical fields may be useful to chemosensitize tumours for
chemotherapeutic treatment. Since electrical fields can be applied
locally, an increased doxorubicin toxicity in the target area may be
achieved with lower doses of orally or intravenously administered
drug as are currently applied during conventional chemotherapy.
The in vitro approach of the present study may initiate in vivo
investigations with the aim of selectively increasing anthracycline
uptake in the diseased organ rather than the whole body, which –
when lower doses of the cytostatic are applied – should result in
less severe side-effects for the patient.
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